Overview

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
0
Participant gender:
Female
Summary
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- 20-90 years old female patients going through vaginal hysterctomy

Exclusion Criteria:

- massive bleeding during operation due to major vessles injury

- known coagulopathies

- sensitivity to tranexamic acid

- medical need in tranexamic acid administration during operation due to bleeding